| 000 | 01737 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517095831.0 | ||
| 264 | 0 | _c20170601 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1551-4005 | ||
| 024 | 7 |
_a10.1080/15384101.2016.1189041 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAnwar, Tarique | |
| 245 | 0 | 0 |
_aIncreased expression of SIRT2 is a novel marker of cellular senescence and is dependent on wild type p53 status. _h[electronic resource] |
| 260 |
_bCell cycle (Georgetown, Tex.) _c07 2016 |
||
| 300 |
_a1883-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylation _xdrug effects |
| 650 | 0 | 4 |
_aAcetylcysteine _xpharmacology |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 |
_aCell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCellular Senescence _xdrug effects |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 | _aGene Knockdown Techniques |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMitochondrial Proteins _xmetabolism |
| 650 | 0 | 4 | _aOncogenes |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 |
_aSirtuin 2 _xmetabolism |
| 650 | 0 | 4 |
_aSirtuins _xmetabolism |
| 650 | 0 | 4 |
_aStress, Physiological _xdrug effects |
| 650 | 0 | 4 |
_aSubstrate Specificity _xdrug effects |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 700 | 1 | _aKhosla, Sanjeev | |
| 700 | 1 | _aRamakrishna, Gayatri | |
| 773 | 0 |
_tCell cycle (Georgetown, Tex.) _gvol. 15 _gno. 14 _gp. 1883-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/15384101.2016.1189041 _zAvailable from publisher's website |
| 999 |
_c26063080 _d26063080 |
||